ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 119 filers reported holding ORAMED PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,361 | -11.6% | 19,679 | +21.2% | 0.00% | – |
| Q2 2023 | $58,133 | +47.8% | 16,239 | -10.1% | 0.00% | – |
| Q1 2023 | $39,332 | -85.4% | 18,056 | -19.6% | 0.00% | -100.0% |
| Q4 2022 | $270,000 | +67.7% | 22,459 | -9.1% | 0.00% | – |
| Q3 2022 | $161,000 | +83.0% | 24,701 | +28.6% | 0.00% | – |
| Q2 2022 | $88,000 | -35.8% | 19,203 | +17.4% | 0.00% | – |
| Q1 2022 | $137,000 | -63.5% | 16,354 | -37.7% | 0.00% | -100.0% |
| Q4 2021 | $375,000 | -2.8% | 26,267 | +49.5% | 0.00% | 0.0% |
| Q3 2021 | $386,000 | +282.2% | 17,570 | +131.5% | 0.00% | – |
| Q2 2021 | $101,000 | +110.4% | 7,588 | +60.6% | 0.00% | – |
| Q1 2021 | $48,000 | +1100.0% | 4,725 | +372.5% | 0.00% | – |
| Q4 2020 | $4,000 | +33.3% | 1,000 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 366,401 | $2,374,000 | 2.07% |
| Private Portfolio Partners LLC | 67,400 | $436,752 | 0.12% |
| Knoll Capital Management, LLC | 20,000 | $130,000 | 0.08% |
| ETF MANAGERS GROUP, LLC | 94,493 | $612,000 | 0.02% |
| Virtu Financial LLC | 21,526 | $139,000 | 0.01% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 21,904 | $142,000 | 0.01% |
| BOURGEON CAPITAL MANAGEMENT LLC | 5,627 | $36,000 | 0.01% |
| Walleye Capital LLC | 78,418 | $508,000 | 0.01% |
| Jump Financial, LLC | 36,100 | $234,000 | 0.01% |
| Plante Moran Financial Advisors, LLC | 7,911 | $51,000 | 0.01% |